(Q37979289)

English

From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia.

scientific article published on June 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

title

From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

main subject

schizophrenia

0 references

cognitive dysfunction

1 reference

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

author name string

P A Gaspar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

M L Bustamante

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

A Martinez

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

publication date

1 June 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

published in

Current Pharmaceutical Biotechnology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 January 2020

page(s)

1543-1548

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22283759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22283759%20AND%20SRC:MED&resulttype=core&format=json

(Q37979289)

From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)